Inhibition of Ocular Neovascularization by Co-Inhibition of VEGF-A and PLGF
Background/Aims: Age-related macular degeneration (AMD) appears to be a disease with increasing incidence in Western countries and may develop into acquired blindness. Choroidal neovascularization (CNV) is the most frequent cause for AMD, and is commonly induced by regional inflammation. Past studie...
Main Authors: | Xiaochuan Huo, Youxiang Li, Yuhua Jiang, Xiaoyun Sun, Lixue Gu, Wenshi Guo, Dapeng Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2015-03-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/373990 |
Similar Items
-
Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
by: Yingbin Fu, et al.
Published: (2024-02-01) -
Knockdown of the Placental Growth Factor Gene Inhibits Laser Induced Choroidal Neovascularization in a Murine Model
by: Ramin Nourinia, et al.
Published: (2013-01-01) -
Combined Anti-PLGF and Anti-Endostatin Treatments Inhibit Ocular Hemangiomas
by: Hua Jiang, et al.
Published: (2015-06-01) -
A new rat model of treatment-naive quiescent choroidal neovascularization induced by human VEGF165 overexpression
by: Shan Liu, et al.
Published: (2020-06-01) -
Recent advance on anti-VEGF treatment of choroidal neovascularization secondary to pathological myopia
by: Xing-Zhao Xu, et al.
Published: (2018-09-01)